142 related articles for article (PubMed ID: 36533709)
1. High expression of caspase-8 as a predictive factor of poor prognosis in patients with esophageal cancer.
Chai J; Lei Y; Xiang X; Ye J; Zhao H; Yi L
Cancer Med; 2023 Mar; 12(6):7651-7666. PubMed ID: 36533709
[TBL] [Abstract][Full Text] [Related]
2. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data.
Li D; Deng W; Huang G; Xiao X
Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
4. Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer.
Hou J; Yang Y; Gao H; Ouyang T; Liu Q; Ding R; Kan H
Medicine (Baltimore); 2022 Oct; 101(40):e30888. PubMed ID: 36221371
[TBL] [Abstract][Full Text] [Related]
5. m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer.
Tuersun H; Liu L; Zhang J; Maimaitizunong R; Tang X; Li H
Transl Cancer Res; 2023 Sep; 12(9):2319-2335. PubMed ID: 37859733
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer.
Fang X; Wang J; Chen J; Zhuang M; Huang T; Chen Z; Huang Y; Zheng B; Wang X
Front Genet; 2022; 13():851390. PubMed ID: 35464847
[No Abstract] [Full Text] [Related]
7. Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma.
Liu XS; Gao Y; Wu LB; Wan HB; Yan P; Jin Y; Guo SB; Wang YL; Chen XQ; Zhou LM; Yang JW; Kui XY; Liu XY; Pei ZJ
Front Oncol; 2021; 11():665388. PubMed ID: 34123828
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.
Gan W; Wang W; Li T; Zhang R; Hou Y; Lv S; Zeng Z; Yan Z; Yang M
J Cancer; 2022; 13(5):1588-1602. PubMed ID: 35371307
[No Abstract] [Full Text] [Related]
9. Caprin-1 plays a role in cell proliferation and Warburg metabolism of esophageal carcinoma by regulating METTL3 and WTAP.
Gao Y; Yuan L; Ke C; Pei Z; Liu X; Wu R; Kui X; Zhang Y
J Transl Med; 2023 Feb; 21(1):159. PubMed ID: 36855123
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma.
Liu XS; Kui XY; Gao Y; Chen XQ; Zeng J; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Genet; 2022; 13():835265. PubMed ID: 35401696
[No Abstract] [Full Text] [Related]
11. Comprehensive Analysis of Hexokinase 2 Immune Infiltrates and m6A Related Genes in Human Esophageal Carcinoma.
Liu XS; Liu JM; Chen YJ; Li FY; Wu RM; Tan F; Zeng DB; Li W; Zhou H; Gao Y; Pei ZJ
Front Cell Dev Biol; 2021; 9():715883. PubMed ID: 34708035
[No Abstract] [Full Text] [Related]
12. Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer.
Chen Y; Huang X; Chen L; Weng G; Huang Z; Zhang Y; Xiao T; Chen J; Zhu K; Xu Y
Mol Biotechnol; 2023 Mar; 65(3):361-383. PubMed ID: 35780460
[TBL] [Abstract][Full Text] [Related]
13. Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal Cancer.
Viet-Nhi NK; Minh Quan T; Cong Truc V; Anh Bich T; Hoang Nam P; Le NQK; Chen PY; Hung SH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473938
[TBL] [Abstract][Full Text] [Related]
14. Investigation on the Potential Correlation Between
Yao L; Zhong X; Huang G; Ma Q; Xu L; Xiao H; Guo X
Front Cell Dev Biol; 2021; 9():730337. PubMed ID: 34778250
[No Abstract] [Full Text] [Related]
15. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
Front Immunol; 2022; 13():950365. PubMed ID: 36159855
[TBL] [Abstract][Full Text] [Related]
16. Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma.
Zhang Y; Zhang J; Pan G; Guan T; Zhang C; Hao A; Li Y; Ren H
World J Surg Oncol; 2021 Aug; 19(1):242. PubMed ID: 34399788
[TBL] [Abstract][Full Text] [Related]
17. A novel mitochondria-related gene signature in esophageal carcinoma: prognostic, immune, and therapeutic features.
Zhang X; Wu H; Niu J; Hu Y; Zhang W; Chang J; Li L; Zhu J; Zhang C; Liu M
Funct Integr Genomics; 2023 Mar; 23(2):109. PubMed ID: 36991225
[TBL] [Abstract][Full Text] [Related]
18. Screening of potential key genes in esophageal cancer based on RBP and expression verification of HENMT1.
Reyimu A; Xing F; Zhou W; Zheng Y; Liu B; Dai J; Xing Y; Gao J
Medicine (Baltimore); 2023 Dec; 102(49):e36544. PubMed ID: 38065897
[TBL] [Abstract][Full Text] [Related]
19. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis.
Cao X; Wu B; Guo S; Zhong W; Zhu S; Zhang Z; Gu L; Li H
Pathol Oncol Res; 2023; 29():1610976. PubMed ID: 36969562
[No Abstract] [Full Text] [Related]
20.
Liu SP; Li XM; Liu DM; Xie SH; Zhang SB; Li Y; Xie ZF
Front Oncol; 2022; 12():884448. PubMed ID: 35530327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]